| Application no. and date | 16800098.2 (espacenet) (Federated) (European Patent Register), 20160526 | | Patent/reg. no. and date | DK/EP 3305891, 20210106 | | Publication date | 20180411 | | Priority no. and date | JP 2015107147, 20150527 | | EP pub. no. and date |
EP 3305891 20180411 | | Effective date | | | Applicant/owner | Astellas Pharma Inc., 5-1, Nihonbashi-Honcho
2-chome
Chuo-ku
Tokyo 103-8411, JP | | Applicant ref. no. | P75458DK01 | | Inventor | TAKAGI, Yasuhiro, c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411, JP,
KIKUCHI, Takuya, c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411, JP | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C12N 1/00 (2006.01) , C12N 5/07 (2010.01) , C12N 5/10 (2006.01) , C12N 5/18 (2006.01) , C12P 21/02 (2006.01) , C12P 21/08 (2006.01) | | Title | CELLEDYRKNINGSFREMGANGSMÅDE SOM ANVENDER NUKLEINSYRE-HOLDIGT MEDIUM | | Int. application no. | JP2016065625 | | Int. publication no. | WO2016190394 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
